The groundbreaking success of Viagra undeniably revolutionized the medication landscape, but betting in companies primarily reliant on unbranded versions presents a complex picture. Despite early returns were significant, the end of patents and the emergence of less expensive alternatives have weakened sales. Thus, a thorough analysis of ongoing in